Excess Iron – The Iron Overload Resource for International HCPs

Signs of iron overload (also known as excess iron) may be seen after as few as 10 red blood cell transfusions, making iron overload a common secondary disease among transfusion-dependent patients. Patients with chronic severe anemias caused by thalassaemia, sickle cell disease, and myelodysplastic syndromes requiring blood transfusions are at greatest risk.

The most common cause of iron overload is hereditary haemochromatosis, a condition linked to a mutation of the HFE gene. Among untreated homozygous patients, the disorder typically leads to significant iron overload by the 4th or 5th decade of life.

Excessiron.com, your excess iron resource, helps keep you informed with the latest news on
haematology and iron overload.

The Global Iron Summit was held November 7-8, 2008 in Athens, Greece, Click here to view the Summit agenda, faculty presentations and bios.

Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty
Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases
Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation

Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine
5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation